Tricyclic carboxamides for controlling arthropods

US11825838B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11825838-B2
Application numberUS-201816498674-A
CountryUS
Kind codeB2
Filing dateMar 26, 2018
Priority dateMar 31, 2017
Publication dateNov 28, 2023
Grant dateNov 28, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates, inter alia, to compounds of general formula (I). The invention also relates to methods for synthesizing the compounds of formula (I). The compounds according to the invention are in particular suitable for controlling insects, arachnids and nematodes in agricultural applications and for controlling ectoparasites in veterinary medicine.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) in which R 1 is H, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 7 -cycloalkyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, C 6 -,C 10 -,C 14 -aryl(C1-C3)-alkyl, 3, 4, 5, 6, 7, 8, 9 or 10-membered heterocyclyl or 3, 4, 5, 6, 7, 8, 9 or 10-membered-heterocyclyl(C 1 -C 3 )-alkyl, optionally in each case mutually independently substituted by one or more substituents, selected from the group consisting of amino, hydroxyl, halogen, nitro, cyano, isocyano, mercapto, isothiocyanato, C 1 -C 4 -carboxyl, carbonamide, SF 5 , aminosulfonyl, C 1 -C 4 -alkyl, C 3 -C 4 -cycloalkyl, C 2 -C 4 -alkenyl, C 5 -C 6 -cycloalkenyl, C 2 -C 4 -alkynyl, N-mono-C 1 -C 4 -alkylamino, N,N-di-C 1 -C 4 -alkylamino, N—C 1 -C 4 -alkanoylamino, C 1 -C 4 -alkoxy, C 2 -C 4 -alkenyloxy, C 2 -C 4 -alkynyloxy, C 3 -C 4 -cycloalkoxy, C 5 -C 6 -cycloalkenyloxy, C 1 -C 4 -alkoxycarbonyl, C 2 -C 4 -alkenyloxycarbonyl, C 2 -C 4 -alkynyloxycarbonyl, C 6 -,C 10 -,C 14 -aryloxycarbonyl, C 1 -C 4 -alkanoyl, C 2 -C 4 -alkenylcarbonyl, C 2 -C 4 -alkynylcarbonyl, C 6 -,C 10 -,C 14 -arylcarbonyl, C 1 -C 4 -alkylsulfanyl, C 3 -C 4 -cycloalkylsulfanyl, C 1 -C 4 -alkylthio, C 2 -C 4 -alkenylthio, C 5 -C 6 -cycloalkenylthio, C 2 -C 4 -alkynylthio, C 1 -C 4 -alkylsulfenyl and C 1 -C 4 -alkylsulfinyl, wherein both enantiomers of the C 1 -C 4 -alkylsulfinyl group are included, C 1 -C 4 -alkylsulfonyl, N-mono-C 1 -C 4 -alkylaminosulfonyl, N,N-di-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylphosphinyl, C 1 -C 4 -alkylphosphonyl, wherein for C 1 -C 4 -alkylphosphinyl or C 1 -C 4 -alkylphosphonyl both enantiomers are included, N—C 1 -C 4 -alkylaminocarbonyl, N,N-di-C 1 -C 4 -alkylaminocarbonyl, N—C 1 -C 4 -alkanoylaminocarbonyl, N—C 1 -C 4 -alkanoyl-N—C 1 -C 4 -alkylaminocarbonyl, C 6 -,C 10 -,C 14 -aryl, C 6 -,C 10 -,C 14 -aryloxy, benzyl, benzyloxy, benzylthio, C 6 -,C 10 -,C 14 -arylthio, C 6 -,C 10 -,C 14 -arylamino, benzylamino, heterocyclyl and trialkylsilyl; R 2 is H or C 1 -C 6 -alkyl, optionally substituted by one or more substituents mutually independently selected from the group consisting of amino, hydroxyl, halogen, nitro, cyano, mercapto, C 1 -C 4 -carboxyl, carbonamide, aminosulfonyl, C 1 -C 4 -alkyl, C 3 -C 4 -cycloalkyl, C 2 -C 4 -alkenyl, C 5 -C 6 -cycloalkenyl, C 2 -C 4 -alkynyl, N-mono-C 1 -C 4 -alkylamino, N,N-di-C 1 -C 4 -alkylamino, N—C 1 -C 4 -alkanoylamino, C 1 -C 4 -alkoxy, C 2 -C 4 -alkenyloxy, C 2 -C 4 -alkynyloxy, C 3 -C 4 -cycloalkoxy, C 5 -C 6 -cycloalkenyloxy, C 1 -C 4 -alkoxycarbonyl, C 2 -C 4 -alkenyloxycarbonyl, C 2 -C 4 -alkynyloxycarbonyl, C 6 -,C 10 -,C 14 -aryloxycarbonyl, C 1 -C 4 -alkanoyl, C 2 -C 4 -alkenylcarbonyl, C 2 -C 4 -alkynylcarbonyl, C 6 -,C 10 -,C 14 -arylcarbonyl, C 1 -C 4 -alkylsulfanyl, C 3 -C 4 -cycloalkylsulfanyl, C 1 -C 4 -alkylthio, C 2 -C 4 -alkenylthio, C 5 -C 6 -cycloalkenylthio, C 2 -C 4 -alkynylthio, C 1 -C 4 -alkylsulfenyl and C 1 -C 4 -alkylsulfinyl, wherein both enantiomers of the C 1 -C 4 -alkylsulfinyl group are included, C 1 -C 4 -alkylsulfonyl, N-mono-C 1 -C 4 -alkylaminosulfonyl, N,N-di-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylphosphinyl, C 1 -C 4 -alkylphosphonyl, wherein both enantiomers are included for C 1 -C 4 -alkylphosphinyl or C 1 -C 4 -alkylphosphonyl, N—C 1 -C 4 -alkylaminocarbonyl, N,N-di-C 1 -C 4 -alkylaminocarbonyl, N—C 1 -C 4 -alkanoylaminocarbonyl, N—C 1 -C 4 -alkanoyl-N—C 1 -C 4 -alkylaminocarbonyl, C 6 -,C 10 -,C 14 -aryl, C 6 -,C 10 -,C 14 -aryloxy, benzyloxy, benzylthio, C 6 -,C 10 -,C 14 -arylthio, C 6 -,C 10 -,C 14 -arylamino, benzylamino, heterocyclyl and trialkylsilyl; the moieties A 1 , A 2 and A 3 are each independently N, O, CR 3 , S or N—R 4 , wherein A 1 , A 2 , A 3 , Z and the carbon atom of the ring form an aromatic system; R 3 is each independently H, Cl, F, I, Br or optionally halogenated C 1 -C 4 -alkyl; R 4 is each independently H or optionally halogenated C 1 -C 4 -alkyl; Q is O or S; Z is C or N; B 1 , B 2 , B 4 , and B 5 are each independently C—R 5 and wherein R 5 is each independently H, halogen, cyano, nitro, SF 5 , C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkoxy, N—C 1 -C 6 -alkoxyimino-C 1 -C 3 -alkyl, C 1 -C 6 -alkylsulfanyl, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -alkylsulfonyl, N—C 1 -C 6 -alkylamino or N,N-di-C 1 -C 6 -alkylamino, in each case optionally substituted by one or more substituents selected from the group consisting of amino, hydroxyl, halogen, nitro, cyano, isocyano, mercapto, isothiocyanato, C 1 -C 4 -carboxyl, carbonamide, SF 5 , aminosulfonyl, C 1 -C 4 -alkyl, C 3 -C 4 -cycloalkyl, C 2 -C 4 -alkenyl, C 5 -C 6 -cycloalkenyl, C 2 -C 4 -alkynyl, N-mono-C 1 -C 4 -alkylamino, N,N-di-C 1 -C 4 -alkylamino, N—C 1 -C 4 -alkanoylamino, C 1 -C 4 -alkoxy, C 2 -C 4 -alkenyloxy, C 2 -C 4 -alkynyloxy, C 3 -C 4 -cycloalkoxy, C 5 -C 6 -cycloalkenyloxy, C 1 -C 4 -alkoxycarbonyl, C 2 -C 4 -alkenyloxycarbonyl, C 2 -C 4 -alkynyloxycarbonyl, C 6 -,C 10 -,C 14 -aryloxycarbonyl, C 1 -C 4 -alkanoyl, C 2 -C 4 -alkenylcarbonyl, C 2 -C 4 -alkynylcarbonyl, C 6 -,C 10 -,C 14 -arylcarbonyl, C 1 -C 4 -alkylsulfanyl, C 3 -C 4 -cycloalkylsulfanyl, C 1 -C 4 -alkylthio, C 2 -C 4 -alkenylthio, C 5 -C 6 -cycloalkenylthio, C 2 -C 4 -alkynylthio, C 1 -C 4 -alkylsulfenyl and C 1 -C 4 -alkylsulfinyl, wherein both enantiomers of the C 1 -C 4 -alkylsulfinyl group are included, C 1 -C 4 -alkylsulfonyl, N-mono-C 1 -C 4 -alkylaminosulfonyl, N,N-di-C 1 -C 4 -alkylaminosulfonyl, C 1 -C 4 -alkylphosphinyl, C 1 -C 4 -alkylphosphonyl, wherein both enantiomers are included for C 1 -C 4 -alkylphosphinyl or C 1 -C 4 -alkylphosphonyl, N—C 1 -C 4 -alkylaminocarbonyl, N,N-di-C 1 -C 4 -alkylaminocarbonyl, N—C 1 -C 4 -alkanoylaminocarbonyl, N—C 1 -C 4 -alkanoyl-N—C 1 -C 4 -alkylaminocarbonyl, C 6 -,C 10 -,C 14 -aryl, C 6 -,C 10 -,C 14 -aryloxy, benzyl, benzyloxy, benzylthio, C 6 -,C 10 -,C 14 -arylthio, C 6 -,C 10 -,C 14 -arylamino, benzylamino, heterocyclyl and trialkylsilyl; B 3 is CR 5 , wherein R 5 is perhalogenated C 1 -C 4 -alkyl; T is one of the following listed 5-membered heteroaromatics T1-T4 and T6, wherein the bond to is marked with a hash #, and/or a salt, N-oxide and/or tautomeric form of a compound of formula (I). 2. The compound as claimed in claim 1 , wherein R 2 is H or methyl. 3. The compound as claimed in claim 1 , wherein T is T1, T2 or T4. 4. The compound as claimed in claim 1 , wherein R 1 is benzyl, cyclopropyl or 1-CN-cyclopropyl. 5. The compound as claimed in claim 1 , wherein the compound is a compound according to one of formulae of formula (Ia), (Ib), (1j), or (1k) wherein V is N(R 1 R 2 ). 6. The compound as claimed in claim 1 , wherein the compound is a compound of formula (I′a) 7. The compound as claimed in claim 1 , wherein the compound is a compound of formula (I′b) 8. The compound as claimed in claim 1 , wherein the compound is a compound of formula (I′c)

Assignees

Inventors

Classifications

  • A01N33/26Primary

    containing nitrogen-to-nitrogen bonds, e.g. azides, diazo-amino compounds, diazonium compounds, hydrazine derivatives · CPC title

  • 1,2-Diazoles; Hydrogenated 1,2-diazoles · CPC title

  • 1,3-Thiazoles; Hydrogenated 1,3-thiazoles · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • C07D409/04Primary

    directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11825838B2 cover?
The invention relates, inter alia, to compounds of general formula (I). The invention also relates to methods for synthesizing the compounds of formula (I). The compounds according to the invention are in particular suitable for controlling insects, arachnids and nematodes in agricultural applications and for controlling ectoparasites in veterinary medicine.
Who is the assignee on this patent?
Bayer Cropscience Ag
What technology area does this patent fall under?
Primary CPC classification A01N33/26. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).